MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2020-11-20
Chart by TradingView
1/9
Piotroski F — financial health
1.29
Altman Z″ — distress risk · grey
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $185.7M | $259.2M | $288.9M | $883.0M | $799.2M |
| Gross profit | $34.0M | $108.3M | $140.2M | — | — |
| Operating income | -$215.3M | -$235.6M | -$31.6M | $574.2M | $554.6M |
| Net income | -$130.8M | -$144.8M | -$119.0M | $220.2M | $182.0M |
| Operating cash flow | -$57.6M | $7.5M | $126.2M | $536.0M | $368.6M |
| Free cash flow | -$70.7M | -$22.2M | $60.7M | $518.9M | $353.7M |
| Total assets | $770.6M | $1.0B | $1.5B | $2.3B | $1.9B |
| Total liabilities | $397.9M | $431.0M | $697.6M | $1.4B | $1.4B |
| Shareholders' equity | $372.7M | $577.2M | $789.9M | $905.2M | $545.4M |
| Ratios | |||||
| Gross margin | 18.3% | 41.8% | 48.5% | — | — |
| Operating margin | -115.9% | -90.9% | -11.0% | 65.0% | 69.4% |
| Net margin | -70.4% | -55.9% | -41.2% | 24.9% | 22.8% |
| FCF margin | -38.1% | -8.6% | 21.0% | 58.8% | 44.3% |
| Return on assets | -17.0% | -14.4% | -8.0% | 9.6% | 9.5% |
| Return on equity | -35.1% | -25.1% | -15.1% | 24.3% | 33.4% |
| Debt / equity | 0.78× | 0.51× | 0.66× | 0.58× | 0.96× |
| Current ratio | 6.60 | 7.53 | 8.00 | 7.70 | 7.89 |
| Revenue growth | -28.3% | -10.3% | -67.3% | 10.5% | 181.3% |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 4,264,689 | $12.1M |
| Point72 Asset Management, L.P. | 3,205,496 | $9.1M |
Why these scores methodology →
Piotroski F-score: 1/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 1.29 (grey)
- Working capital / assets 0.326
- Retained earnings / assets 0.013
- EBIT / assets -0.279
- Equity / liabilities 0.937
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001823239 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.